StockNews.com Initiates Coverage on Moleculin Biotech (NASDAQ:MBRX)

Stock analysts at StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. Separately, HC Wainwright reissued a “buy” rating and issued a $3.00 target price on shares of Moleculin Biotech in […]

Related Keywords

Walterv Klemp , ,Charles Schwab Investment Management Inc ,Moleculin Biotech Inc ,Citadel Advisors ,Atticus Wealth Management ,Renaissance Technologies ,Moleculin Biotech ,Get Free Report ,Biotech Stock Down ,Schwab Investment Management ,Wealth Management ,State Street Corp ,Street Corp ,Moleculin Biotech Daily ,Nasdaq Mbrx ,Ambrx ,Medical ,Initiated Coverage ,Stocknews Com ,